Emmanuel Zorn, Ph.D.
Dr. Zorn is an Assistant Professor of Clinical Sciences at Columbia University. Dr. Zorn received a Ph.D. in tumor immunology from Paris University in 1999 for his studies on human melanoma antigens. He then joined Dana-Farber Cancer Institute in Boston, MA, where he studied the role of regulatory T cells in chronic graft versus host disease in humans. Dr. Zorn setup his research laboratory at the Massachusetts General Hospital Transplant Center in 2006 to work on human kidney graft rejection. He moved to the CCTI at Columbia University Medical Center in 2014, where he now directs a human transplantation immunology research laboratory. He is also the Director of the CCTI Biobank core. The primary focus of Dr. Zorn’s lab is on B cells and antibodies in mechanisms of rejection or acceptance of kidney and heart transplants.